# In Vivo and In Vitro Mechanisms of Equol Synthesis and Key Influencing Factors: A Critical Review

**Authors:** Tianmeng Zhang, Botao Wang, Chen Wang, Junying Bai, Jingwen Zhou, Jian Chen

PMC · DOI: 10.3390/nu17213449 · Nutrients · 2025-10-31

## TL;DR

This review explores how equol is synthesized in the body and in labs, focusing on factors and methods to improve its production for health benefits.

## Contribution

The paper highlights synthetic biology and gene editing as promising approaches to enhance equol synthesis efficiency.

## Key findings

- Traditional synthesis methods achieve 85–96% efficiency but depend heavily on substrates and microbial species like Escherichia coli.
- Hydrogen and dietary factors significantly influence in vivo and in vitro equol production.
- Synthetic biology and gene editing offer potential breakthroughs for efficient equol synthesis.

## Abstract

Background: Equol exists in two enantiomers of S-equol and R-equol. The results of cell and animal experiments, as well as clinical trials, have supported its protective effects on menopausal symptoms, aging, and cardiovascular diseases, especially S-equol, which is a naturally occurring, non-racemic isomer produced by intestinal bacteria. However, the selective response of host microorganisms to soy isoflavones limits the exploitation of equol-producing bacterial resources. Additionally, factors such as low efficiency, byproduct generation, and environmental pollution hinder the further development and the application of traditional equol synthesis techniques. Methods: Therefore, in this review, we aimed to describe the forms and scope of equol, key influencing factors (e.g., hydrogen and dietary factors) of in vivo and in vitro equol synthesis, and potential molecular mechanisms of equol produced by microorganisms. Notably, the traditional synthesis technology has effectively improved the synthesis efficiency of equol (85–96%), but the substrates and microbial species (such as Escherichia coli) remain the key influencing factors. Results: This review suggests that breakthroughs based on synthetic biology and gene editing technology will support the efficient in vitro synthesis of equol. Conclusions: This review serves as a valuable reference for future research.

## Linked entities

- **Chemicals:** equol (PubChem CID 91469), S-equol (PubChem CID 91469), R-equol (PubChem CID 6950272), soy isoflavones (PubChem CID 70267806)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** cardiovascular diseases (MESH:D002318)
- **Chemicals:** hydrogen (MESH:D006859), isoflavones (MESH:D007529), R-equol (-), Equol (MESH:D060754)
- **Species:** Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12610683/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12610683/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12610683/full.md

---
Source: https://tomesphere.com/paper/PMC12610683